Yung-Jue Bang

发表

Adenovirus-uteroglobin suppresses COX-2 expression via inhibition of NF-kappaB activity in lung cancer cells.

Jung Min Yoon, Y. Bang, S. Han, 2005, Lung cancer.

In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines

Y. Bang, Yung-Jue Bang, Sunkyu Kim, 2003, Peptides.

AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity

Tae-You Kim, Noe Kyeong Kim, Jung Weon Lee, 2004, Oncogene.

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.

Satoshi Morita, Yasuo Ohashi, Junichi Sakamoto, 2013, Journal of the National Cancer Institute.

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib.

Young Tae Kim, Doo Hyun Chung, Tae-You Kim, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines.

Jin Won Kim, Young-Kwang Yoon, Tae-You Kim, 2008, Cancer letters.

Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies

Tae-You Kim, Jae-Yong Chung, Noe Kyeong Kim, 2004, Clinical Cancer Research.

Treatment of ALK-positive non-small cell lung cancer.

Y. Bang, Yung-Jue Bang, 2012, Archives of pathology & laboratory medicine.

A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors

Gopinath Ganji, J. Tolson, Shanker Kalyana-Sundaram, 2017, Clinical Cancer Research.

Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer

Tae-Yong Kim, Jin Won Kim, Woo Ho Kim, 2015, Clinical Cancer Research.

Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase

Jung-Hyun Park, Sang Gyun Kim, Tae-You Kim, 2007, Journal of Molecular Medicine.

The potential for crizotinib in non-small cell lung cancer: a perspective review

Y. Bang, Yung-Jue Bang, 2011, Therapeutic advances in medical oncology.

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis.

Satoshi Morita, Yasuo Ohashi, Junichi Sakamoto, 2013, European journal of cancer.

Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis.

Satoshi Morita, Yasuo Ohashi, Junichi Sakamoto, 2013, Journal of the National Cancer Institute.

Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions

Y. Bang, H. Chae, Deug Y. Shin, 2004, Oncogene.

Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells

Tae-You Kim, Sung-Hak Kim, Y. Bang, 2008, Molecular Cancer Therapeutics.

Cdk2-dependent Phosphorylation of the NF-Y Transcription Factor and Its Involvement in the p53-p21 Signaling Pathway*

Roberto Mantovani, Y. Bang, R. Mantovani, 2003, Journal of Biological Chemistry.

KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach

Young-Kwang Yoon, Tae-You Kim, Y. Bang, 2010, Molecular carcinogenesis.

HER2-targeted therapies — a role beyond breast cancer

Y. Bang, D. Oh, Yung-Jue Bang, 2019, Nature Reviews Clinical Oncology.

Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis

S. Markowitz, Y. Bang, Y. Im, 2000 .

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor α-negative breast cancer cells to tamoxifen

Eun Ryoung Jang, Soo-Jeong Lim, Tae-You Kim, 2004, Oncogene.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yoon-Koo Kang, Taroh Satoh, Lin Shen, 2010, The Lancet.

Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma.

Hansoo Lee, Yun-Sil Lee, Hae-Yeong Kim, 2003, Biochemical and biophysical research communications.

Identification of genes differentially expressed between gastric cancers and normal gastric mucosa with cDNA microarrays.

Woo Ho Kim, Seongeun Lee, Y. Bang, 2002, Cancer letters.

Mass spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: Comparison to IHC and FISH

Wei-Li Liao, Sheeno Thyparambil, Todd Hembrough, 2015, bioRxiv.

Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells

Young-Kwang Yoon, Tae-You Kim, Hye-Jin Kim, 2012, Anti-cancer drugs.

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer.

Young-Kwang Yoon, Tae-You Kim, Hyun-Jin Nam, 2011, Cancer letters.

Free-breathing dynamic contrast-enhanced MRI of the abdomen and chest using a radial gradient echo sequence with K-space weighted image contrast (KWIC)

Simon Bauer, Kai Tobias Block, Berthold Kiefer, 2013, European Radiology.

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2

Young-Kwang Yoon, Tae-You Kim, Ju-Hee Lee, 2009, PloS one.

Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers

Tae-You Kim, Y. Bang, Tae-You Kim, 2008, Laboratory Investigation.

Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX

Tae-Yong Kim, Kyu Joo Park, Seung-Yong Jeong, 2015, Clinical Epigenetics.